About 100 reports

  • 5.3 FIRST-IN-CLASS PIPELINE PROGRAMS TARGETING NOVEL MOLECULAR TARGETS
  • Asthma Therapeutics Market, Global, Pipeline Programs Targeting CC Chemokine Receptor Type-3, 2016

In the case of allergic diseases, and possibly asthma, an imbalance between T-helper (Th) ## and Th## cytokines has been postulated (NHLBI, 2007).

  • Cytokine
  • World
  • Almirall, S.A.
  • Genentech, Inc.
  • Novartis AG

MARKET ##.

  • Cytokine
  • APAC
  • Europe
  • Japan
  • World
  • 7.1 SEGMENTATION-BY CYTOKINE TYPE
  • North American Cytokine Market in USD million, by Cytokine type, 2014 to 2022

Cytokine Market In 2016, the global cytokine market was valued at USD XX million. Considering the historical trend and possible future developments, the market is projected to reach USD XX million by 2022, registering a CAGR of XX%, during 2017-2022 (the forecast period). Cytokines are a group of immune-mediators,...

  • Cytokine
  • North America
  • United States
  • World
  • Market Size
  • Interferon Major Producer and Their Market Share

The auto exports exceeded over ## million each year.

  • Cytokine
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • Interleukin
  • Interleukin

The auto exports exceeded over ## million each year.

  • Cytokine
  • China
  • Demand
  • Harbin Pharmaceutical Group
  • North China Pharmaceutical Group Corp.
  • Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Discontinued Products
  • Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) Overview

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016’, provides in depth analysis on Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF...

  • Cytokine
  • Interleukin
  • Turkey
  • United States
  • Product Initiative
  • Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Discontinued Products
  • Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) Overview

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF...

  • Cancer
  • Cytokine
  • United States
  • Product Initiative
  • ARMO Biosciences, Inc.
  • Rheumatoid Arthritis, Global, Pipeline by Molecular Target and Stage of Development, 2016
  • 4.3 EPIDEMIOLOGY

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation Summary Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable auto-immune disease that affects the joints, and is characterized by synovial inflammation and hyperplasia. It occurs...

  • Arthritis
  • Cytokine
  • Pathology
  • World
  • Deals & Alliance
  • C) Pipeline breakdown of cytokine and cytokine receptors
  • 4.4.4 THE ROLE OF CYTOKINES

Frontier Pharma: Transplantation Therapeutics - A Highly Innovative Pipeline with a Range of Adaptive and Innate Immune-Targeting Programs Focusing on Graft-Versus-Host Disease and Kidney Transplantation Summary In 2015, more than of 125,000 transplantations were performed worldwide, an increase...

  • Cytokine
  • General Medicine And Specialty Medicine
  • Transplantation
  • World
  • Deals & Alliance
  • CYTOSORB - CYTOKINE RELEASE SYNDROME - PRODUCT DESCRIPTION
  • CYTOSORB - CYTOKINE ADSORPTION IN SEPSIS AND ACUTE KIDNEY INJURY

Blood Purification Equipment - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Blood Purification Equipment - Medical Devices Pipeline Assessment, 2017" provides an overview of Blood Purification Equipment currently in pipeline stage. The report provides comprehensive...

  • Blood Supply
  • Clinical Trial
  • Cytokine
  • Therapy
  • GlobalData's company
  • SEP 13, 2017: BIONIZ THERAPEUTICS PRESENTS DATA DEMONSTRATING THE SYNERGISTIC EFFECTS OF CYTOKINES IL-15 AND IL-21 IN CELIAC DISEASE PATHOGENESIS
  • JAN 04, 2018: IMMUSANT PROVIDES YEAR-END UPDATE AND OUTLINES GOALS FOR 2018

Celiac Disease - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Celiac Disease - Pipeline Review, H1 2018, provides an overview of the Celiac Disease (Gastrointestinal) pipeline landscape. Celiac disease is an autoimmune...

  • Cytokine
  • Digestive System Disorder
  • Therapy
  • United States
  • Product Initiative
  • CYTOSORB - CYTOKINE RELEASE SYNDROME
  • CYTOSORB - CYTOKINE ADSORPTION IN SEPSIS AND ACUTE KIDNEY INJURY

Summary CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that specializes in the development of blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriously...

  • Cytokine
  • Specialty Hospital
  • United States
  • Demand
  • CytoSorbents Corporation
  • DAROMUN - DRUG PROFILE

April ##, 2017, ##:## - ##:## p. m.

  • Cytokine
  • Therapy
  • United States
  • World
  • Product Initiative
  • R-191 - DRUG PROFILE
  • R&D Progress Research and Development Brief

Inhibition of IRAK blocks the TLR##- and IL-##R-induced cytokine production and elicits therapeutic activity.

  • Cytokine
  • Therapy
  • United States
  • World
  • Product Initiative
  • AN-4161 - DRUG PROFILE

GOUTVAX IS AN IL-## BETA, A PROINFLAMMATORY CYTOKINE CANDIDATE.

  • Chronic Disease
  • Cytokine
  • Therapy
  • United States
  • Product Initiative
  • Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Drug Profiles

The three Nimbus novel compounds, ND-##, ND-## and ND-## demonstrated high selectivity against a panel of ## kinases, and potent in vitro inhibition of cytokine production in cells and whole blood.

  • Autoimmune Disease
  • Cytokine
  • United States
  • World
  • Product Initiative
  • Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Drug Profiles
  • same indication granted in Europe in July 2012 from the European Commission.

The current study of safety and activity of CYT## treatment in genotype ## and ## patients resistant to one or multiple lines of SOC focuses on one of the more difficult segments of the HCV patient population and strongly supports the potential of additional studies with th

  • Cytokine
  • United States
  • World
  • Product Initiative
  • Cytheris SA
  • Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) Overview
  • Mechanism Of Action

Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) targeted pipeline therapeutics. The...

  • Autoimmune Disease
  • Cytokine
  • World
  • Product Initiative
  • Novartis AG
  • Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Drug Profiles

The molecules developed by companies in Phase II, Phase I and Preclinical stages are ##, ## and ## respectively.

  • Biological Therapy
  • Cytokine
  • Therapy
  • World
  • Product Initiative
  • MONOCLONAL ANTIBODY THAT BINDS SELECTIVELY TO INTERLEUKIN-1 BETA (IL-1 BETA), ONE OF THE INFLAMMATORY CYTOKINES, NEUTRALIZING ITS ACTIVITY.
  • SOBI-006 - DRUG PROFILE

Interleukin 1 (IL1) - Pipeline Review, H1 2018 Summary According to the recently published report ’Interleukin 1 (IL1) - Pipeline Review, H1 2018’; Interleukin 1 (IL1) pipeline Target constitutes close to 22 molecules. Out of which approximately 21 molecules are developed by companies and remaining...

  • Cytokine
  • Hospital
  • Therapy
  • United States
  • Product Initiative
  • Target
  • Target

## (Cytokine Receptor Class II Member ## or Cytokine Receptor Family ## Member ## or Type I Interferon Receptor ## or IFNAR##) Agonist; Interferon Alpha/ Beta Receptor ## (Interferon Alpha Binding Protein or Type I Interferon Receptor ## or IFNAR##) A

  • Clinical Trial
  • Cytokine
  • Monoclonal Antibody
  • Neurological Disorder
  • Biogen Idec Inc.
  • BNZ-1 - DRUG PROFILE
  • Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) Overview

ZIOPHARM' s pipeline products include Ad-RTS-IL-## and CAR/ Cytokine Products.

  • Cytokine
  • Pharmaceutical
  • Prostate Cancer
  • Vaccine
  • OncBioMune Pharmaceuticals, Inc.
  • DAROMUN - DRUG PROFILE

April ##, 2017, ##:## - ##:## p. m.

  • Cytokine
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative
  • CV-18C3 - DRUG PROFILE
  • RA-18C3 - DRUG PROFILE

Interleukin ## Alpha (IL ## Alpha or Hematopoietin ## or IL##A) Overview Interleukin ## alpha or hematopoietin ## is a protein of the interleukin ## family encoded by the IL##A gene.

  • Cytokine
  • Therapy
  • Europe
  • European Union
  • XBiotech Inc.
  • R&D Progress
  • Mechanism Of Action

Interleukin 15 (IL15) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 15 (IL15) - Pipeline Review, H1 2016’, provides in depth analysis on Interleukin 15 (IL15) targeted pipeline therapeutics. The report provides comprehensive information on the Interleukin 15 (IL15), targeted therapeutics,...

  • Cytokine
  • Monoclonal Antibody
  • Turkey
  • World
  • Product Initiative

When the drug candidate binds to the receptors, it blocks or modulates the actions of the cytokines responsible for neutrophil recruitment.

  • Breast Cancer
  • Cytokine
  • Therapy
  • Transplantation
  • Dompe Farmaceutici S.p.A.
  • Clinical Trial profile. 113 Trial Title
  • 3. GDCT ID IS THE UNIQUE ID OF GLOBALDATA'S PHARMA INTELLIGENCE CENTER CLINICAL TRIAL DATABASE

Hoffmann-La Roche Ltd ## ## ## ## ## ## Eli Lilly and Co ## ## ## ## ## ## Asklepion Pharmaceuticals LLC ## ## ## ## ## ## Altor BioScience Corp ## ## ## ## ## ## Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials a

  • Biological Therapy
  • Cytokine
  • Drug Discovery And Development
  • World
  • Product Initiative

MARKET ##.

  • Biological Therapy
  • Cytokine
  • APAC
  • World
  • Company Sales

When the drug candidate binds to the receptors, it blocks or modulates the actions of the cytokines responsible for neutrophil recruitment.

  • Breast Cancer
  • Cytokine
  • Therapy
  • Transplantation
  • Dompe Farmaceutici S.p.A.
  • SMALL MOLECULE INFLAMMASOME MODULATOR PROGRAMME - DRUG PROFILE
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

Interleukin ## beta is a cytokine protein encoded by the IL##B gene.

  • Biotechnology
  • Cytokine
  • Hospital
  • Therapy
  • Novartis AG